Trial Profile
Prospective, randomized, crossover study of regular and modified release Tacrolimus in renal transplant recipients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 03 Nov 2015 New trial record